Conatus Pharmaceuticals Inc. (CNAT): Price and Financial Metrics


Conatus Pharmaceuticals Inc. (CNAT)

Today's Latest Price: $0.38 USD

0.00 (0.00%)

Updated Feb 28 12:12pm

Add CNAT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

CNAT Stock Summary

  • CNAT has a higher market value than only 5.84% of US stocks; more precisely, its current market capitalization is $13,832,093.
  • With a year-over-year growth in debt of -96.8%, Conatus Pharmaceuticals Inc's debt growth rate surpasses merely 2.29% of about US stocks.
  • In terms of volatility of its share price, CNAT is more volatile than 93.21% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Conatus Pharmaceuticals Inc, a group of peers worth examining would be MGEN, KALV, ORMP, RCUS, and BCRX.
  • Visit CNAT's SEC page to see the company's official filings. To visit the company's web site, go to www.conatuspharma.com.
CNAT Daily Price Range
CNAT 52-Week Price Range

CNAT Stock Price Chart More Charts


CNAT Price/Volume Stats

Current price $0.38 52-week high $3.08
Prev. close $0.38 52-week low $0.25
Day low $0.37 Volume 177,044
Day high $0.40 Avg. volume 1,046,990
50-day MA $0.42 Dividend yield N/A
200-day MA $0.42 Market Cap 12.60M

Conatus Pharmaceuticals Inc. (CNAT) Company Bio


Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. The company was founded in 2005 and is based in San Diego, California.


CNAT Latest News Stream


Event/Time News Detail
Loading, please wait...

CNAT Latest Social Stream


Loading social stream, please wait...

View Full CNAT Social Stream

CNAT Price Returns

1-mo -18.28%
3-mo 2.81%
6-mo 11.11%
1-year -80.41%
3-year -92.20%
5-year -94.03%
YTD -5.00%
2019 -76.88%
2018 -62.55%
2017 -12.33%
2016 82.99%
2015 -58.86%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7488 seconds.